Targeting angiogenin in therapy of amyotropic lateral sclerosis

Author： Kishikawa Hiroko   Wu David   Hu Guo-fu  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.10, 2008-10, pp. : 1229-1242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current pharmacological management of amyotropic lateral sclerosis and a role for rational polypharmacy

By Weiss Michael D   Weydt Patrick   Carter Gregory T  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 735-746

Informa Healthcare

Access to resources Recommend Favorite

Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis

By Bedlack Richard S   Traynor Bryan J   Cudkowicz Merit E  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 229-252

Informa Healthcare

Access to resources Recommend Favorite

A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies

By Yamamoto Masahiko   Tanaka Fumiaki   Tatsumi Hiroshi   Sobue Gen  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1845-1857

Informa Healthcare

Access to resources Recommend Favorite

Targeting Astrocytes for Treatment in Amyotrophic Lateral Sclerosis

By  

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5037-5044

Bentham Science Publishers

Access to resources Recommend Favorite

New therapy options for amyotrophic lateral sclerosis

By Gordon Paul   Corcia Philippe   Meininger Vincent  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1907-1917

Informa Healthcare

Access to resources Recommend Favorite